Hakutulokset - Estelle Verronèse

  • Näytetään 1 - 5 yhteensä 5 tuloksesta
Tarkenna hakua
  1. 1
    Human Langerhans Cells Express a Specific TLR Profile and Differentially Respond to Viruses and Gram-Positive Bacteria

    Human Langerhans Cells Express a Specific TLR Profile and Differentially Respond to Viruses and Gram-Positive Bacteria Tekijä Vincent Flacher, Marielle Bouschbacher, Estelle Verronèse, Catherine Massacrier, Vanja Sisirak, Odile Berthier‐Vergnes, Blandine de Saint‐Vis, Christophe Caux, Colette Dezutter‐Dambuyant, Serge Lebecque, Jenny Valladeau

    Julkaistu 2006
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay

    Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay Tekijä Estelle Verronèse, Ana Sofia Delgado, Jenny Valladeau‐Guilemond, G. Garin, Séverine Guillemaut, Olivier Trédan, Isabelle Ray‐Coquard, Thomas Bachelot, Axelle Nkodia, C. Bardin-dit-Courageot, Chantal Rigal, David Pérol, Christophe Caux, Christine Ménétrier‐Caux

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Human natural killer cells promote cross‐presentation of tumor cell‐derived antigens by dendritic cells

    Human natural killer cells promote cross‐presentation of tumor cell‐derived antigens by dendritic cells Tekijä Florence Deauvieau, Vincent Ollion, Anne‐Claire Doffin, Carole Achard, Jean‐François Fonteneau, Estelle Verronèse, Isabelle Durand, Raffaella Ghittoni, Jacqueline Marvel, Colette Dezutter‐Dambuyant, Thierry Walzer, Henri Vié, Ivan Perrot, Nadège Goutagny, Christophe Caux, Jenny Valladeau‐Guilemond

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients.

    ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients. Tekijä Olivier Trédan, Christine Ménétrier‐Caux, Isabelle Ray‐Coquard, G. Garin, Claire Cropet, Estelle Verronèse, Thomas Bachelot, Paul Rebattu, Pierre-Étienne Heudel, Philippe A. Cassier, Sylvie Chabaud, Thérèse Croughs, Pierre Dupont, A.C. Cadore, Gilles Clapisson, Ana Sofia Delgado, C. Bardin-dit-Courageot, Chantal Rigal, Axelle Nkodia, Laurence Gilles-Afchain, Michel Morre, David Pérol, Jean‐Yves Blay, Christophe Caux

    Julkaistu 2015
    Hae kokoteksti
    Errata/Corrigenda
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator–dependent autoimmunity

    PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator–dependent autoimmunity Tekijä Anne‐Laure Mathieu, Estelle Verronèse, Gillian Rice, Fanny Fouyssac, Yves Bertrand, Capucine Pïcard, Marie Chansel, Jolán E. Walter, Luigi D. Notarangelo, Manish J. Butte, Kari C. Nadeau, Krisztián Csomós, David J. Chen, Karin Chen, Ana Sofia Delgado, Chantal Rigal, Christine Bardin, Catharina Schuetz, Despina Moshous, Héloïse Reumaux, François Plénat, Alice Phan, Marie-Thérèse Zabot, B. Balme, Sébastien Viel, Jacques Bienvenu, Pierre Cochat, Mirjam van der Burg, Christophe Caux, E. Helen Kemp, Isabelle Rouvet, Christophe Malcus, Jean-Francois Méritet, Apiradee Lim, Yanick J. Crow, Nicole Fabien, Christine Ménétrier‐Caux, Jean‐Pierre de Villartay, Thierry Walzer, Alexandre Bélot

    Julkaistu 2015
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: